Literature DB >> 15505995

Cortisol, depression and reduced cortico-cortical cross-talk in Cushing's syndrome.

D J L G Schutter1, J van Honk, E H F de Haan, A C van Huffelen, H P F Koppeschaar, H P F Koppeschar.   

Abstract

In the present report assumed relationships between hypercortisolism, depression and cortico-cortical cross-talk in Cushing's syndrome were investigated. Electroencephalographic (EEG) recordings and depression ratings from three patients diagnosed with mild, moderate and severe hypercortisolism were obtained. Reductions in cortico-cortical cross-talk as quantified by EEG coherence together with increases in depression were observed in the moderate and severe as compared to the mild hypercorticolism state. These findings provide preliminary evidence for the hypothesis that loss of cortico-cortical cross-talk might be linked to hypercortisolism and the severity of depressive symptoms.

Entities:  

Mesh:

Year:  2004        PMID: 15505995     DOI: 10.1007/bf03347504

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  27 in total

Review 1.  Cushing's syndrome.

Authors:  M Boscaro; L Barzon; F Fallo; N Sonino
Journal:  Lancet       Date:  2001-03-10       Impact factor: 79.321

2.  Cortisol and reduced interhemispheric coupling between the left prefrontal and the right parietal cortex.

Authors:  Dennis J L G Schutter; Jack Van Honk; Hans Koppeschaar; Rene Kahn
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2002       Impact factor: 2.198

3.  Counterintuitive antidepressant properties of slow rTMS over the left frontal cortex: a possible mechanism.

Authors:  Dennis J L G Schutter; Alfredo A L D'Alfonso; Jack Van Honk
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

4.  An open label trial of C-1073 (mifepristone) for psychotic major depression.

Authors:  Joseph K Belanoff; Anthony J Rothschild; Frederick Cassidy; Charles DeBattista; Etienne-Emile Baulieu; Clifford Schold; Alan F Schatzberg
Journal:  Biol Psychiatry       Date:  2002-09-01       Impact factor: 13.382

5.  The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.

Authors:  L D Dorn; E S Burgess; T C Friedman; B Dubbert; P W Gold; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1997-03       Impact factor: 5.958

6.  Salivary cortisol levels and stress reactivity in human aging.

Authors:  N Nicolson; C Storms; R Ponds; J Sulon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1997-03       Impact factor: 6.053

7.  Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.

Authors:  B E Murphy; D Filipini; A M Ghadirian
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

8.  Basal cortisol levels and cognitive deficits in human aging.

Authors:  S Lupien; A R Lecours; I Lussier; G Schwartz; N P Nair; M J Meaney
Journal:  J Neurosci       Date:  1994-05       Impact factor: 6.167

Review 9.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

10.  Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486.

Authors:  L K Nieman; G P Chrousos; C Kellner; I M Spitz; B C Nisula; G B Cutler; G R Merriam; C W Bardin; D L Loriaux
Journal:  J Clin Endocrinol Metab       Date:  1985-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.